Free Resources
A wide selection of reports covering top issues in pharma and health care.
-
Should Avastin keep its Breast Cancer Indication?
February 3, 2011
Physician reactions to the FDA's decision to rescind the indication for Avastin in the treatment of breast cancer.
-
Utility of Social Networks for Physicians and Life Sciences
January 10, 2011
How physicians are using social networks, and how life science companies can reach them.
-
Potential Replacements for Coumadin (warfarin)
November 24, 2010
Physicians discuss their awareness and understanding of potential replacements for coumadin, as well as barriers to prescribing.
-
FDA-Required REMS a Potential Barrier
October 21, 2010
Physicians perspectives on the FDA-required Erythropoiesis-Stimulating Agents (ESAs) risk evaluation and mitigation strategy (REMS) program.
-
Ticagrelor is Likely to Affect the Standard of Care
August 25, 2010
Insight into evolving trends of CML.
See what Sermo Business Solutions can do for you. Contact Us